B. Braun Anticipates Becoming First to Deliver FDA Approved 2g Cefazolin
Approval for Antibiotic Delivered in DUPLEX Delivery System Pending
BETHLEHEM, Pa., June 2 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it anticipates
U.S. Food and Drug Administration (FDA) approval for 2g Cefazo...
Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing
NORTH ANDOVER, Mass., March 24 /PRNewswire-FirstCall/ -- Andover
Medical, Inc. (OTC Bulletin Board: ADOV), a single source provider of
orthopedic durable medical equipment ("DME"), announced today that the
closing a $2.0 million private financing with an
ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
CHARLES TOWN, W.Va., Oct. 11 /PRNewswire-FirstCall/ -- ReBuilder
Medical Technologies, Inc. (Pink Sheets: RBRM), an emerging medical device
manufacturer founded by world-renowned medical device inventor David B.
Phillips, Ph.D., today announced it has agreed with Helio Health
Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance
Based on the above revisions, the Company is now anticipating CNI per share to be $0.05 per share higher than previously forecasted. The Company anticipates
CNI per share to in the range of $1.60 to $1.65.
The Company's full year 2009 revised guidance is summarized on the last exhibit to this relea...
Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer
...te cancer. The disease-specific trial is being conducted under a Bellicum Investigational New Drug application allowed by the FDA in 2008. The company anticipates
reporting initial results of the study in 2010.
BP-GMAX-CD1 is a novel cancer vaccine that can be precisely activated at an optimal time and lo...
XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution
... The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. The Company currently anticipates
that, on or about August 17, 2009, the Company will file with the Securities and Exchange Commission and NASDAQ a Form 25 relating to the delisting of...
NMPI Launches Fifth Portable Cardiology Unit
...all regulatory standards and provide physicians with an opportunity to keep revenues in house."
With demand steadily increasing, Mr. Millett anticipates
adding a sixth camera before the end of the year. "Expansion is actually running about 6 months ahead of schedule. The acquisition of a sixth c...
Chesson Labs Liquid Bandage Product NUVADERM(TM) Receives FDA 510(k) Market Clearance
...nce is a significant milestone for Chesson Labs because it is their first medical device submission to the FDA and first 510(k) clearance. The Company anticipates
submission of additional filings to the FDA as it continues to expand its product portfolio.
"NUVADERM's clearance is a major milestone for Che...
Streamline Health Appoints Jon Phillips Chairman of the Board of Directors
...any's Chairman of the Board since the Company's inception, will continue as a director and as Chief Executive Officer of the Company.
The Board anticipates
that the Chairman of the Board will serve for a two-year term, subject to annual re-election by shareholders. Mr. Phillips' initial term as Chairman ...
Landauer, Inc. Reports Fiscal 2009 Third Quarter Results
The Company's business plan for fiscal 2009 currently anticipates
aggregate revenue growth for the year to be in the range of 3 - 5 percent. The Company currently anticipates
a net income increase in the range of 6 - 8 percent, prior to the $1.8 mill...
anticipates in Medical Technology
American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- The American Legion
welcomes the findings of an Institute of Medicine (IOM) report on
Deployment Related Stress scheduled to be released on Nov 14.
"In view of the serious and widespread impact of stress on the health
of military personnel who h...
FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
...maining labeling language
over the next 4 to 8 weeks.
"Shire is confident that we will quickly come to agreement on the final
product label and anticipates
a launch in the fourth quarter as planned,"
said Mike Cola, President of Shire Specialty Pharmaceuticals. "When approved,
INTUNIV will be the first se...
Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
...se and should not be relied upon as reflecting the company's views, expectations or beliefs at any date subsequent to the date of this release. Idenix anticipates
that subsequent events and developments may cause these views, expectations and beliefs to change. However, while Idenix may elect to update these for...
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
...y and safety data are available at this time. Further analyses are planned, including analyses of additional secondary endpoints. Jazz Pharmaceuticals anticipates
submitting a New Drug Application for sodium oxybate to the U.S. Food and Drug Administration (FDA) by the end of 2009. UCB will consult with the Euro...
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
...udy is Dr. Linda Vahdat, Medical Director of the Breast Cancer Research Program and Associate Professor of Clinical Medicine, /Weill Cornell. CuraGen anticipates
presenting updated results from this study during the second half of 2009.
CR011-vcMMAE is an antibody-drug conjugate (ADC...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
...round mid-2009. Assuming positive results for the second study, the company anticipates
submitting a New Drug Application for sodium oxybate for the treatment of f...bromyalgia to the U.S. Food and Drug Administration by the end of 2009. UCB anticipates
filing in the EU shortly after. UCB has the exclusive marketing and distrib...
Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
...gression-free survival, time to progression, overall survival and safety. To date, more than 140 patients have been enrolled in the study. Proteolix anticipates
reporting results from this accelerated approval trial in the first half of 2010.
Carfilzomib Active in Single-Agent and Combination Regimens
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
...ny, Ltd. (Shionogi), initiated a Phase 3 program with i.v. peramivir in the outpatient setting. The Phase 3 study is a 1,050 subject study. BioCryst anticipates
that Shionogi will complete its study within this influenza season and expects to file for new drug approval in Japan by fiscal year end. Shionogi in...
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
...red to fiscal year 2008, and another reduction of approximately $11.1 million for fiscal year 2010, compared to fiscal year 2009.
The Company now anticipates
that with current cash, cash equivalents and marketable securities along with interest earned thereon, expected payments from Symphony Allegro, the pr...
Jubilant Enters Research Collaboration With AstraZeneca
...iding a robust global drug discovery model. Through
this partnership, Jubilant is confident of contributing to AstraZeneca's
preclinical portfolio and anticipates
significant rewards from successful
downstream milestones. This partnership furthers Jubilant's strategy to be
India's largest provider of innovative ...
anticipates in Medical Products
Features:...data, all the time – the information loop is
seamless among all caregivers. XLTEK’s intuitive software
downstream events – you won’t find yourself
constantly caught in computer gridlock – so your focus
anticipates in Biological News
Great (taste) expectations: Study shows brain anticipates taste, shifts gears
As the prism of our senses, the human brain has ways of refracting sensory input in defiance of reality.
This is seen, for example, in the placebo effect, when simple sugar pills or inert salves taken by unwitting subjects are seen to ease pain or have some other beneficial physiological effect. ...
Silicon with afterburners: Process developed at Rice could be boon to electronics manufacturer
...of dollars and millions of person-years invested into it. So we decided it would be good to complement silicon, rather than try to supplant it."
wide industry interest in the process, in which carbon molecules could be bonded with silicon either through a chemical bath or evaporation. "This is ...
Report shows the power of US cities to mitigate climate change and steps they need to take to adapt
...report says 14 cities see general opportunities arising from climate change, including energy efficiency and a strengthening of communities. New York anticipates
that "efforts to mitigate greenhouse gas emissions from government operations will save the city hundreds of millions of dollars in energy costs in th...
Conservationists seek to identify prime stopover sites for migrating birds
... from the Nature Conservancy and in-kind support from the Audubon Society began the last week of April and will run through the end of May. The effort anticipates
the launch this fall of a federally funded three-year project to be administered by the Nature Conservancy.
"Conservation of migratory birds requir...
Clinical trials for shingles drug take an important step forward
...Inhibitex reported no serious adverse events in healthy volunteers and data supported the potential for once-a-day dosing in future trials. Inhibitex anticipates
completing its first Phase II trial of FV-100 in the first half of 2010.
Russell H. Plumb, president and chief executive officer of Inhibitex, Inc...
Two Hutchinson Center researchers named HHMI Early Career Scientists
...ensitize tumors to cancer therapies.
Malik and Taniguchi will begin their six-year, nonrenewable HHMI appointments in September 2009. The Institute anticipates
another Early Career Scientist competition in 2012.
K-State researchers work with university in Ghana to create biofuels from native tree seeds
...ofuels, Kpikpi's project envisions cultivating these trees specifically for biodiesel production on land that isn't suitable to grow food. The project anticipates
economic opportunities for people in Ghana by producing this type of biodiesel.
Wenqiao "Wayne" Yuan, K-State assistant professor of biological and...
Researchers capture wave of brain activity linked to anticipation
... WASHINGTON, D.C. Neuroscientists at Georgetown University Medical Center have, for the first time, shown what brain activity looks like when someone anticipates
an action or sensory input which soon follows.
In the February 25 issue of the Journal of Neuroscience , they say this neural clairvoyance involve...
K-State research: Freshwater pollution costs US at least $4.3 billion a year
...logy; Joshua Schloesser, August 2008 master's graduate in biology; and Darren Thornbrugh, December 2007 master's graduate in biology.
Dodds said he anticipates
the research being used by policymakers because it documents the extent of the nutrient pollution problem in the United States and one facet of why it...
How to build crops that can beat aluminum's toxic effects
...opsis offer "readymade" tools for genetically engineering crop plants incapable of restricting root growth in response to Al toxicity, Larsen said. He anticipates
that introduction of the mutant versions of AtATR into crop plants would override the existing assessment mechanisms and allow for continued cell divi...
anticipates in Biological Technology
CalbaTech Files Nine Month Financial Results; Anticipates Profitability in 2007
LAGUNA HILLS, Calif., Nov. 20 /PRNewswire-FirstCall/ -- CalbaTech, Inc.
(OTC BB: CLBE), an emerging life sciences company ( http://www.CalbaTech.com
) concentrating on the collection and banking of adult stem cells for
possible future therapeutic uses and providing products and platforms to
Synthetech Reports First Quarter Fiscal 2010 Results
...omer base. In addition, the full benefit of our cost reduction plan implemented in the first quarter begins in the second quarter."
that Synthetech's revenue will continue to be volatile from period to period. Variability in Synthetech's level of revenue is based primarily on its ...
Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
...ely $86.2 million.
Financial Outlook for 2009
Cadence currently anticipates
that total operating expenses for 2009 will be between $50.0 million and $5...unmet medical needs or enhance patient care, the timeframe in which Cadence anticipates
receiving regulatory approval for Acetavance, and the company's financial p...
NxStage Reports Second Quarter 2009 Financial Results
In addition, the statements in this press release represent NxStage's expectations and beliefs as of the date of this press release. NxStage anticipates
that subsequent events and developments may cause these expectations and beliefs to change. However, while NxStage may elect to update these forward-l...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
...t development and consumer testing with both new and reformulated established products in larger countries that are high-volume users of MSG. Senomyx anticipates
that Nestle will initiate commercialization of established products containing the savory flavor ingredients later this year.
- Sweet Enhance...
Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia
... The Company intends to meet with and work closely with the Agency to design and establish a protocol under a Special Protocol Assessment. The company anticipates
that initiation of the additional Phase 3 program could take place in the first half of 2010. Advanced Life Sciences is working collaboratively on the...
ERT Reports Second Quarter 2009 Results
The Company issued guidance for the third quarter of 2009 and for the full year 2009. For the quarter ending September 30, 2009, management anticipates
net revenues of between $23.0 million and $25.0 million and diluted net income per share of between $0.05 and $0.07. ERT expects full year 2009 net r...
Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
...hs from the date of issuance at an exercise price of $0.60 per share (the "Series B Warrants"). In connection with the private placement, the Company anticipates
that it will receive aggregate proceeds, excluding costs and expenses, in the amount of $530,000. In addition, Cato Holding Company has agreed to can...
Caliper Life Sciences Reports Second Quarter 2009 Results
... The $343
of 2009 revenue included remaining first quarter revenues
associated with the AutoTrace product lines. The Company
no further revenue from either of the former
PDQ or AutoTrace product lines in 2009.
CALIPER LIFE SCIENCES, INC.
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
...,250 shares of the Company's common stock. The offering is expected to close on August 3, 2009, subject to customary closing conditions. The Company anticipates
net proceeds from the offering of approximately $310 million.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )